ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 161 filers reported holding ARCUS BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,220,755 | -11.6% | 1,405,056 | 0.0% | 1.19% | +7.2% |
| Q2 2023 | $28,536,687 | +0.3% | 1,405,056 | -9.9% | 1.11% | -11.9% |
| Q1 2023 | $28,453,433 | -49.1% | 1,559,947 | -42.3% | 1.26% | -37.2% |
| Q4 2022 | $55,903,975 | -36.8% | 2,703,287 | -20.1% | 2.00% | -37.5% |
| Q3 2022 | $88,505,000 | +4.4% | 3,383,233 | +1.1% | 3.20% | -1.0% |
| Q2 2022 | $84,799,000 | -21.7% | 3,346,458 | -2.5% | 3.24% | -20.1% |
| Q1 2022 | $108,283,000 | -22.0% | 3,431,010 | 0.0% | 4.05% | -14.4% |
| Q4 2021 | $138,853,000 | +16.1% | 3,431,010 | 0.0% | 4.73% | +34.4% |
| Q3 2021 | $119,639,000 | +24.5% | 3,431,010 | -1.9% | 3.52% | +16.8% |
| Q2 2021 | $96,062,000 | -2.2% | 3,498,260 | 0.0% | 3.01% | +0.4% |
| Q1 2021 | $98,231,000 | +4.8% | 3,498,260 | -3.1% | 3.00% | -9.0% |
| Q4 2020 | $93,735,000 | +96.9% | 3,610,760 | +30.0% | 3.30% | +49.8% |
| Q3 2020 | $47,597,000 | +10.9% | 2,776,932 | +60.0% | 2.20% | -1.2% |
| Q2 2020 | $42,938,000 | +282.1% | 1,735,581 | +114.4% | 2.23% | +141.3% |
| Q1 2020 | $11,236,000 | +372.1% | 809,511 | +266.3% | 0.92% | +1365.1% |
| Q4 2018 | $2,380,000 | -76.4% | 220,976 | -69.5% | 0.06% | -57.4% |
| Q3 2018 | $10,090,000 | +7.3% | 723,834 | -5.8% | 0.15% | +0.7% |
| Q2 2018 | $9,404,000 | -34.7% | 768,279 | -17.7% | 0.15% | -49.8% |
| Q1 2018 | $14,410,000 | – | 933,286 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |